Following extensive research, the ReDiRECt project has successfully pinpointed promising drug candidates for repurposing in bladder cancer. These candidates have exhibited anti-cancer effects in pre-clinical models, and further clinical testing is planned.
Rotenburger Str. 20
D-30659 Hannover
Germany
Phone: +49 (0)511 55 47 44 0
Fax: +49 (0)511 55 47 44 31
Copyright © 2024 Imprint